Dr. Sulaiman Al Habib Medical S
"Sector" = median of Healthcare across 84 companies
About Dr. Sulaiman Al Habib Medical S
AI-generatedDr. Sulaiman Al Habib Medical Services Group (also known as HMG) is the largest private healthcare provider in Saudi Arabia, operating a network of hospitals, medical centers, pharmacies, and diagnostic labs. Founded in 1993, the company offers a comprehensive range of medical services including general and specialized surgeries, cardiology, oncology, pediatrics, and maternity care. It also provides home healthcare, telemedicine, and wellness programs. HMG is recognized for its high-quality care and has expanded into the UAE and other Gulf markets.
The company generates revenue primarily from patient care services, including inpatient and outpatient treatments, surgeries, and diagnostic procedures. Additional revenue comes from pharmacy sales, laboratory services, and medical equipment rentals. HMG operates under a fee-for-service model, with a significant portion of revenue derived from government and private insurance contracts. The company also earns income from its own-brand pharmaceutical and medical supply chain, and from management contracts for third-party facilities.
HMG competes in the highly regulated Saudi healthcare sector, which is characterized by growing demand due to population growth, aging demographics, and government initiatives to privatize healthcare. Key competitors include other large private hospital groups such as Dallah Healthcare, Al Hammadi, and Saudi German Hospital. HMG differentiates itself through its extensive network, brand reputation, and investments in advanced medical technology. The company holds a leading market share in the private healthcare segment and benefits from strong patient loyalty.
The company's primary customers are Saudi nationals and expatriates residing in Saudi Arabia, with a growing focus on medical tourism from neighboring Gulf countries. HMG's facilities are concentrated in major cities like Riyadh, Jeddah, and Dammam, with expansion into the UAE. The company serves a broad demographic, from routine care to complex tertiary procedures. Its target audience includes insured individuals, corporate clients, and government-sponsored patients under the national health insurance scheme.
An auto-generated descriptive profile based on company data, for informational purposes only.
No 24-hour summary has been generated yet.
Financial highlights
Latest saved period: March 2026 · 2026-03-31
Dividend history
Cash dividends by ex-date, not an investment recommendation.
| Ex-date | Amount | Payment date | Period |
|---|---|---|---|
| Feb 23, 2026 | 1.31 SAR | — | — |
| Nov 2, 2025 | 1.21 SAR | — | — |
| Aug 3, 2025 | 1.19 SAR | — | — |
| May 11, 2025 | 1.12 SAR | — | — |
| Feb 24, 2025 | 1.23 SAR | — | — |
| Nov 10, 2024 | 1.20 SAR | — | — |
| Aug 4, 2024 | 1.17 SAR | — | — |
| May 26, 2024 | 1.17 SAR | — | — |
| Feb 25, 2024 | 1.15 SAR | — | — |
| Nov 5, 2023 | 1.17 SAR | — | — |
| Aug 13, 2023 | 1.00 SAR | — | — |
| May 14, 2023 | 1.00 SAR | — | — |
| Feb 26, 2023 | 0.93 SAR | — | — |
| Oct 30, 2022 | 0.86 SAR | — | — |
| Aug 14, 2022 | 0.86 SAR | — | — |
| May 8, 2022 | 0.83 SAR | — | — |
| Apr 19, 2022 | 0.70 SAR | — | — |
| Oct 31, 2021 | 0.70 SAR | — | — |
| Aug 15, 2021 | 0.70 SAR | — | — |
| Apr 28, 2021 | 0.70 SAR | — | — |
| Apr 22, 2021 | 0.60 SAR | — | — |
| Nov 1, 2020 | 0.60 SAR | — | — |
| Aug 23, 2020 | 0.40 SAR | — | — |
| Jul 5, 2020 | 0.50 SAR | — | — |
Revenue
↑ 15.4%Net Income
↓ 15.5%Free Cash Flow
↑ 678.5%Diluted EPS
↓ 15.3%Dr. Sulaiman Al Habib Medical S (4013) analysis
Wrqti brings Dr. Sulaiman Al Habib Medical S data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Stocks related to Dr. Sulaiman Al Habib Medical S
Companies in the Healthcare sector you can compare with Dr. Sulaiman Al Habib Medical S: